Abstract
Dysregulated wound healing, marked by excessive collagen deposition, is the hallmark to keloid scar formation. Current methods for assessing keloids in clinical settings rely heavily on subjective measures, which are prone to interrater variability. This study introduces a machine learning (ML) pipeline prototype, designed to automate the detection, measurement, and colour analysis of keloid scars. Using a convolutional neural network (CNN), the pipeline segments keloid lesions from 2D images, applies fiducial markers for accurate size measurement, and utilizes K-Means clustering for colorimetry analysis. The CNN achieved a classification accuracy of 98% on a small test dataset. Segmentation was further refined using binary masks and contour-based detection.
Colorimetry analysis revealed heterogeneity in pigmentation across keloid lesions, was varied by patient skin type, and tracked changes over time. The pipeline was validated on patients over a 5–6-month period, accurately detecting changes in keloid size and colour. While the algorithm was highly effective in most cases, challenges were noted in patients with nascent keloid or those with dark skin tones where the contrast between keloid and skin was insufficient for accurate segmentation. Additionally, early-stage keloid detection showed inconsistencies in defining lesion boundaries, particularly when keloids expanded rapidly. Despite these limitations, the ML pipeline presents a promising tool for objective keloid assessment, offering a practical, accessible, and accurate alternative to current clinical practices.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Research Council, IRAP program, Canada; Mitacs, Canada
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Research Ethics Board of the National Research Council, Canada gave ethical approval for this work(Protocol 2021-144). The Health Research Ethics board of the University of Alberta gave ethical approval of this study(Protocol HREB Pro00125760).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
ETHICS DECLARATION: This study was approved by the National Research Council-Research Ethics Board(NRC-REB),Canada for Protocol 2021-144 “Building Algorithms for classifying and tracking Skin Abnormalities”. This study was approved by the University of Alberta, Edmonton, Health Research Ethic Board (HREB)-Health Panel, for Protocol(pro) HREB Pro00125760 titled “Validating novel artificial intelligence tool for objective measurement of clinical scar assessment”.
Data Availability
All data produced in the present work are available upon reasonable request to the authors
